Fullerenes against COVID-19: Repurposing C 60 and C 70 to Clog the Active Site of SARS-CoV-2 ProteaseCOVID-19에 대한 풀러렌: SARS-CoV-2 프로테아제의 활성 부위를 막기 위해 C 60 및 C 70 용도 변경Article Published on 2022-03-162022-09-11 Journal: Molecules [Category] SARS, 변종, 신약개발, [키워드] active site Amino acid amino acids Antiviral agents aspecific assist binding binding energy binding pocket C60 C70 carbon catalytic dyad Clog complement Computational chemistry COVID-19 docking drug Drug repurposing effective electrostatic Fullerene inhibitor inhibitors interactions M pro masitinib MM-GBSA molecular molecular dynamics MPro Mutation nanobio interface. protease Protein protonation state repurposing SARS-CoV-2 SARS-CoV-2 protease SARS-CoV-2 virus shown Site the disease the SARS-CoV-2 the SARS-CoV-2 virus Treatment Vaccines variant [DOI] 10.3390/molecules27061916 PMC 바로가기 [Article Type] Article
Psychological stress; knowledge, attitude and practice and acceptance of antiviral therapy in pregnant women with hepatitis B in Zhejiang, China: a case comparison studyArticle Published on 2022-03-092023-06-12 Journal: BMJ Open [Category] B형 간염, [키워드] Antiviral agents hepatitis B patient acceptance of healthcare Pregnant woman Psychological Stress [DOI] 10.1136/bmjopen-2021-055642 PMC 바로가기
Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproachSARS-CoV-2 야생형 및 델타 변이체의 스파이크 단백질에 대한 잠재적 진입 억제제로서의 식물 유래 항바이러스 화합물: SilicoApproach의 통합Article Published on 2022-03-082022-09-11 Journal: Molecules [Category] SARS, 변종, 신약개발, 진단, 치료제, [키워드] antagonists Antiviral Antiviral agents antiviral drug antiviral drugs approach approaches binding affinities binding affinity binding energy binding free energies binding free energy binding interaction carried complexes Compound compounds controls Corilagin country COVID-19 COVID-19 infection Delta delta variant develop docking Efficacy exhibited experimental validation explained FIVE free energies glycoprotein greater H-bonds hydrogen hydrophobic interaction hydrophobic interactions Hypericin in silico India lead Ligand ligands Lupeol molecular molecular docking molecular dynamics molecular dynamics and simulations Molecular modeling mutated phytochemical compounds plant compound Potential Protein Research resulting RMSD RMSF S protein SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 variant second wave selected several variant several variants spike spike glycoprotein Spike protein stability target proteins therapeutic intervention Transmissibility Vaccine Virtual screening virulence was performed while wild-type wild-type SARS-CoV-2 [DOI] 10.3390/molecules27061773 PMC 바로가기 [Article Type] Article
Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy신종 코로나바이러스 감염증 2019(COVID-19) 및 잠재적 치료법으로서의 황화수소의 신장 결과Review Published on 2022-03-012022-09-11 Journal: Nitric oxide : biology and chemistry [Category] SARS, 바이오마커, 치료제, [키워드] Acute kidney injury addition angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 Angiotensin-converting enzyme 2 (ACE2) Anti-inflammatory antioxidant Antiviral antiviral agent Antiviral agents Cancer caused cells Chronic kidney disease clinical study condition consequence coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 patient COVID-19 patients COVID-19 pneumonia Diabetic diabetic nephropathy dialysis enzyme exhibit expression facilitate global pandemic H(2)S donors humans hydrogen Hydrogen sulfide Hydrogen sulfide (H(2)S) increase interleukin-6 kidney Kidney disease kidney dysfunction Kidney injury kidney transplant manifestation Mortality nephropathy Novel coronavirus novel coronavirus disease patients Pneumonia potential therapy prevalent protease reduced renal Renal cancer Respiratory illness SARS-CoV-2 Serine serine 2 serum SULFIDE survivor therapeutic therapy transmembrane transmembrane protease serine 2 Treatment virus [DOI] 10.1016/j.niox.2022.01.002 PMC 바로가기 [Article Type] Review
Improving siRNA design targeting nucleoprotein gene as antiviral against the Indonesian H5N1 virusArticle Published on 2022-03-012023-06-22 Journal: Journal of veterinary science [Category] 조류인플루엔자, [키워드] Antiviral agents H5N1 subtype Indonesia influenza in birds RNA interference [DOI] 10.4142/jvs.21174 PMC 바로가기
Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatientsResearch article Published on 2022-03-012022-10-05 Journal: Infectious diseases now [Category] SARS, 변종, [키워드] age Ageusia Anosmia Antiviral agents Clinical management complete recovery cough COVID-19 COVID-19 outpatient COVID-19 outpatients cycle threshold disease enrolled Factor female Fever Gastrointestinal symptom Gender headache healthcare worker identification individual individuals median age Mild mild COVID-19 myalgia outcome Patient performed persistent Persistent COVID-19 symptoms Prevalence Probability proportion prospective cohort study Prospective Study Result risk factor SARS-CoV-2 RT-PCR Sex Symptom symptomatic Symptoms Viral load women [DOI] 10.1016/j.idnow.2021.11.003 [Article Type] Research article
QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugsSARS-CoV-2에 감염되어 항바이러스제 치료를 받은 환자의 QTc 간격 연장Article Published on 2022-03-012022-09-11 Journal: Anales de pediatria [Category] COVID19(2023년), SARS, 치료제, [키워드] adverse effect affected analyzed Antiviral Antiviral agents antiviral drug antiviral therapy arrhythmia Azithromycin Azitromicin Azitromicina basal baseline caused Child congenital heart disease Control COVID-19 disease electrocardiogram Electrocardiograma Electrocardiograms Electrocardiography English event heart disease Hidroxicloroquina hubo Hydroxychloroquine Immunosuppression increase in infected with SARS-CoV-2 Long Long QT syndrome Lopinavir Lopinavir/ritonavir median no difference no differences paediatric patients Patient patients Pediatría pediatrics QT largo QTc QTc interval QTC prolongation Remdesivir resulting Ritonavir SARS-CoV-2 Spanish treat treated Treatment underlying diseases use of hydroxychloroquine ventricular [DOI] 10.1016/j.anpede.2021.04.006 PMC 바로가기 [Article Type] Article
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity결합 협동성을 활용하는 COVID-19 항바이러스 치료를 위한 SARS-CoV-2 PLpro 억제제의 설계Article Published on 2022-02-242022-09-11 Journal: Journal of medicinal chemistry [Category] 치료제, [키워드] antiviral agent Antiviral agents antiviral potency binding binding affinities binding interaction binding site complement cooperativity COVID-19 COVID-19 pandemic cysteine cysteine protease cysteine proteases glycine Host host protein human cells immune sensing induce inhibitor inhibitory potency Interaction Ligand mimicking New novel overcome Papain-like protease PLPro recognizing regulate reported SARS-CoV-2 Structure substrates therapeutic target translate ubiquitin vaccination viral replication yielding [DOI] 10.1021/acs.jmedchem.1c01307 PMC 바로가기 [Article Type] Article
Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule InhibitorsArticle Published on 2022-02-222023-07-07 Journal: mBio [Category] COVID19(2023년), [키워드] Antiviral agents broad-spectrum antiviral coronavirus COVID-19 fusion inhibitor SARS-CoV-2 structural modeling viral entry viral fusion Viral variants [DOI] 10.1128/mbio.03238-21 PMC 바로가기
Sandacrabins – Structurally Unique Antiviral RNA Polymerase Inhibitors from a Rare MyxobacteriumArticle Published on 2022-02-212023-07-07 Journal: Chemistry (Weinheim an Der Bergstrasse, Germany) [Category] COVID19(2023년), [키워드] Antiviral agents natural products structure elucidation supercritical fluids terpenoids [DOI] 10.1002/chem.202104484 PMC 바로가기